register

News & Trends - Biotechnology

Merck and Microsoft partnerships support Australian-developed COVID-19 vaccine

Health Industry Hub | August 31, 2020 |
[Total: 1    Average: 5/5]

Biotech News: COVAX-19 is the first Australian-developed COVID-19 vaccine to pass phase I clinical trials in Australia successfully. Phase II clinical trials are set to begin in September 2020.

Professor Nikolai Petrovsky is the Director of Endocrinology at Flinders Medical Centre, a Professor in the School of Medicine at Flinders University and the founder of Vaxine Pty Ltd, an Adelaide-based biotechnology company specialising in pandemic vaccine design.

COVAX-19 vaccine comprises a recombinant spike protein antigen formulated with Vaxine’s proprietary Advax adjuvant, which drives a potent T cell and neutralising antibody response against the target virus.

The Microsoft AI and Azure cloud capabilities will help the company accelerate clinical testing of its COVAX-19 vaccine.

“Large international Phase III vaccine trials are extraordinarily complex and generate vast amounts of data that needs to be efficiently processed”, says Vaxine Research Director, Flinders University Professor Nikolai Petrovsky.

“Supported by Microsoft technology, we aim to collect and analyse the COVAX-19 trial data in real time, rather than waiting until the end of the trial before seeing if the vaccine is working, which is the traditional process.”

Merck Life Sciences, Managing Director, Rebecca Lee, conducted a recent Q&A video interview with Professor Nikolai Petrovsky.

Join 22,000+
industry professionals
in accessing the latest 
industry news, scientific insights & engaging professional development 
content from
Health Industry HubTM, 
the ONLY one-stop-hub
connecting Australia’s 
Pharma, MedTech & Biotech
industry professionals. Register now.

Merck has a long-standing relationship with Sypharma and Vaxine for more than 10 years, supporting the manufacture of Advax adjuvants with manufacturing solutions, single-use, filtration products and process development expertise.


News & Trends - Medical Technology

MedTech News -

Ellume and Novartis secure top 10 ranking in AFR Boss Most Innovative Companies List

Health Industry Hub | October 18, 2021 |

MedTech News: Ellume and Novartis have been recognised in the 2021 AFR BOSS top 10 innovations in the health industries […]

More


News & Trends - Medical Technology

Pharma News - ACCC wins interim injunction to halt Virtus acquiring Adora fertility clinics

ACCC wins interim injunction to halt Virtus acquiring Adora fertility clinics

Health Industry Hub | October 18, 2021 |

Pharma News: The ACCC has won an interim injunction blocking IVF provider Virtus Health from completing its purchase of rival Adora Fertility. The ACCC filed proceedings in […]

More


News & Trends - Pharmaceuticals

Pharma News - Australia secures access to two new COVID treatments from Roche and Pfizer

Australia secures access to two new COVID treatments from Roche and Pfizer

Health Industry Hub | October 18, 2021 |

Pharma News: The Australian Government has secured access to two additional COVID-19 treatments to support the National Plan to Transition […]

More


News & Trends - Medical Technology

MedTech News - Private-public partnership facilitates Illawarra region’s first cardiac surgeries

Private-public partnership facilitates Illawarra region’s first cardiac surgeries

Health Industry Hub | October 18, 2021 |

MedTech News: After months of planning, negotiating, fitting out a new theatre and staging ‘dry runs’ of complex procedures, Wollongong […]

More